Arcus Biosciences (RCUS) EPS (Basic) Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -13.31% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -100.00% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -79.34% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 61.11% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3,856.63% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -7.78% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,207.14% |
| 10 | Arcus Biosciences | 3.18 Bn | 2.36 Bn | - | 10.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.53% |
| Dec 31, 2025 | 12.62% |
| Sep 30, 2025 | -27.00% |
| Mar 31, 2025 | -2,180.00% |
| Dec 31, 2024 | 4.63% |
| Sep 30, 2024 | -6.38% |
| Jun 30, 2024 | 1.92% |
| Mar 31, 2024 | 95.41% |
| Dec 31, 2023 | -16.13% |
| Sep 30, 2023 | -4.44% |
| Jun 30, 2023 | -11.83% |
| Mar 31, 2023 | -13.54% |
| Dec 31, 2022 | -123.02% |
| Sep 30, 2022 | 18.92% |
| Jun 30, 2022 | 14.68% |
| Mar 31, 2022 | 11.11% |
| Dec 31, 2021 | 564.37% |
| Sep 30, 2021 | -3,800.00% |
| Jun 30, 2021 | -17.20% |
| Mar 31, 2021 | -71.43% |
| Dec 31, 2020 | -128.95% |
| Sep 30, 2020 | 105.88% |
| Jun 30, 2020 | -45.31% |
| Mar 31, 2020 | -53.66% |
| Dec 31, 2019 | -35.71% |
| Sep 30, 2019 | -104.00% |
| Jun 30, 2019 | -100.00% |
| Mar 31, 2019 | 70.07% |
| Dec 31, 2018 | 95.32% |
| Sep 30, 2018 | 97.89% |
| Jun 30, 2018 | 94.33% |
| Mar 31, 2018 | 72.38% |